Manulife Financial initiated with a Buy at UBS

UBS analyst Michael Ward initiated coverage of Manulife Financial (MFC) with a Buy rating and C$55 price target UBS sees 3% and 8% upside to consensus 2026 and 2027 EPS estimates driven by strength in Asia and Global Wealth and Asset Management, the analyst tells investors in a research note. Asia’s expanding middle class, aging population, and rising demand for retirement and income protection products position MFC well for growth, while ongoing investment in scalable GWAM capabilities-highlighted by the Comvest acquisition-supports momentum in high-value segments and potential earnings-driven re-rating, UBS says.